Stuart Henderson
Directeur/Bestuurslid bij OXFORD BIOMEDICA PLC
Vermogen: 45 776 $ op 31-05-2024
Profiel
Stuart Henderson is currently the Non-Executive Vice Chairman at Oxford Biomedica Plc since 2020.
Previously, he served as the Director at BioCity Group Ltd from 2018 to 2021.
He also held positions as the Director at The Babraham Institute, One Nucleus Ltd., and Norwich Research Partners LLP.
Additionally, he served as a Non-Executive Director at Cell Therapy Catapult Ltd.
Mr. Henderson was a Partner at Deloitte LLP (United Kingdom) and worked at Arthur Andersen LLP from 2004 to 2005.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
OXFORD BIOMEDICA PLC
0.01% | 20-09-2023 | 10 862 ( 0.01% ) | 45 776 $ | 31-05-2024 |
Actieve functies van Stuart Henderson
Bedrijven | Functie | Begin |
---|---|---|
OXFORD BIOMEDICA PLC | Directeur/Bestuurslid | 01-06-2016 |
Eerdere bekende functies van Stuart Henderson
Bedrijven | Functie | Einde |
---|---|---|
BioCity Group Ltd
BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 30-04-2021 |
Deloitte LLP (United Kingdom)
Deloitte LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte LLP (United Kingdom) provides brokerage services. The company is based in London, UK. David Sproul has been the CEO of the British company since 2003. | Corporate Officer/Principal | - |
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | - |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | Directeur/Bestuurslid | - |
One Nucleus Ltd.
One Nucleus Ltd. Miscellaneous Commercial ServicesCommercial Services One Nucleus Ltd. is a life science membership organization that supports the largest life science cluster in the East of England region through knowledge transfer, connectivity, inward investment, and growth. The non-profit company is based in Cambridge, UK. Sphere Fluidics, a British company commercializing single cell analysis systems, introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell. Marks & Clerk, a global intellectual property firm, announced that Associates Graham McGlashan and Erik Rõuk will be attending the 7th International XR Conference, taking place in partnership with The Manchester Metropolitan University, ISCTE - Instituto Universitario de Lisboa and the International Association of Immersive Technology Innovation. BioIVT, a leading provider of research models and services for drug and diagnostic development, recently acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera, and controls. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OXFORD BIOMEDICA PLC | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
BioCity Group Ltd
BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Finance |
The Babraham Institute
The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Commercial Services |
Deloitte LLP (United Kingdom)
Deloitte LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte LLP (United Kingdom) provides brokerage services. The company is based in London, UK. David Sproul has been the CEO of the British company since 2003. | Commercial Services |
One Nucleus Ltd.
One Nucleus Ltd. Miscellaneous Commercial ServicesCommercial Services One Nucleus Ltd. is a life science membership organization that supports the largest life science cluster in the East of England region through knowledge transfer, connectivity, inward investment, and growth. The non-profit company is based in Cambridge, UK. Sphere Fluidics, a British company commercializing single cell analysis systems, introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell. Marks & Clerk, a global intellectual property firm, announced that Associates Graham McGlashan and Erik Rõuk will be attending the 7th International XR Conference, taking place in partnership with The Manchester Metropolitan University, ISCTE - Instituto Universitario de Lisboa and the International Association of Immersive Technology Innovation. BioIVT, a leading provider of research models and services for drug and diagnostic development, recently acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera, and controls. | Commercial Services |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | Commercial Services |
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |